Switches will continue to be pacesetters in O-T-C arena
PARSIPPANY, N.J. — Growth of the U.S. over-the-counter medications market has been primarily driven by prescription-to-OTC switches And that expansion is likely to continue. Due to an increasingly favorable regulatory environment, Kline & Co., a consulting and research firm, forecasts robust prescription-to-OTC switch activity over the next five years with several new OTC categories emerging
